Clinical trials back this up: the STEP trials showed an average weight reduction of around 15% with Semaglutide, while the SURMOUNT trials reported up to 20% with Tirzepatide
Its instability, the absence of any commercial alternative, and the clinical stakes of each preparation make your compounding pharmacy partner one of the most consequential choices in your prescribing practice
V., Wolfe, F., Lisse, J., Furst, D
doi: 10.1177/1179551419875453 75 GasbjergLSChristensenMBChristensenMBHartmannBLanngARSparre-UlrichAHGabeMBNet al
Cellular Longevity: Specialized protocols like NAD+ support DNA repair
Since its typically prescribed for managing chronic conditions like obesity and overweight-related health conditions, semaglutide is usually taken long-term